Townsquare Capital LLC Has $1.83 Million Stake in HealthEquity, Inc. (NASDAQ:HQY)

Townsquare Capital LLC lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,292 shares of the company’s stock after purchasing an additional 839 shares during the quarter. Townsquare Capital LLC’s holdings in HealthEquity were worth $1,825,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Raymond James Trust N.A. boosted its holdings in shares of HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares during the period. Truist Financial Corp lifted its position in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after acquiring an additional 188 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in HealthEquity by 7.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock worth $246,000 after purchasing an additional 198 shares during the period. Elk River Wealth Management LLC increased its holdings in HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after purchasing an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC raised its stake in shares of HealthEquity by 5.8% in the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock valued at $330,000 after purchasing an additional 233 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Bank of America lifted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Finally, JMP Securities restated a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $107.23.

Insider Activity

In other news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock valued at $884,517 over the last ninety days. 2.20% of the stock is currently owned by company insiders.

HealthEquity Trading Down 0.9 %

HealthEquity stock opened at $101.54 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The stock has a 50-day simple moving average of $90.16 and a 200 day simple moving average of $82.81. The stock has a market capitalization of $8.87 billion, a P/E ratio of 84.62, a PEG ratio of 1.59 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $105.82.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The company had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. Analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.